Orexigen Therapeutics (OREX)
Create an Alert
6.33
-0.05 -0.78%
NASDAQ
Jun 19, 5:00PM
BATS Real time
Currency in USD
Orexigen Therapeutics Return on Equity:
-114.9% for Dec. 31, 2012Orexigen Therapeutics Historical Return on Equity Data
Pro Data Export
Dates:
to
There is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| Dec. 31, 2012 | -114.9% |
| Sept. 30, 2012 | -93.18% |
| June 30, 2012 | -59.54% |
| March 31, 2012 | -53.69% |
| Dec. 31, 2011 | -72.67% |
| Sept. 30, 2011 | -128.7% |
| June 30, 2011 | -129.1% |
| March 31, 2011 | -112.4% |
| Dec. 31, 2010 | -95.82% |
| Sept. 30, 2010 | -85.36% |
| June 30, 2010 | -91.59% |
About Return on Equity (ROE)
Return on equity (ROE) measures the rate of return on the money invested by common stock owners and retained by the company thanks to previous profitable years. It demonstrates a company's ability to generate profits from shareholders' equity (also known as net assets or assets minus liabilities).
ROE shows how well a company uses investment funds to generate growth. Return on equity is useful for comparing the profitability of companies within a sector or industry.
Investors generally are interested in company's that have high, increasing returns on equity.
Learn More
OREX Return on Equity Benchmarks
| Companies | |
|---|---|
| Vivus | -66.91% |
| Arena Pharmaceuticals | -86.62% |
| Synergy Pharmaceuticals | -178.1% |
OREX Return on Equity Rankings
| Overall |
59th percentile 6724 of 16782 |
| Sector |
59th percentile 577 of 1410 in Healthcare |
| Industry |
59th percentile 61 of 152 in Drug Manufacturers - Specialty & Generic |
OREX Return on Equity Range, Past 5 Years
| Minimum | -150.7% | Jun 2009 |
| Maximum | -53.69% | Mar 2012 |
| Average | -104.1% |
